BioNTech, the German biotech company that shot to global prominence during the COVID-19 pandemic through its mRNA vaccine partnership with Pfizer, has just signed a $1.5 billion deal with pharmaceutical giant Bristol Myers Squibb. The […]
The post BioNTech Races to Cash In: $1.5 Billion Poured Into Cancer Drug for mRNA ‘Collateral Damage’ appeared first on The People’s Voice.